BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 38416825)

  • 21. Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.
    Castilla LH; Bushweller JH
    Adv Exp Med Biol; 2017; 962():229-244. PubMed ID: 28299661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.
    Wang C; Li L; Li M; Wang W; Liu Y; Wang S
    Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
    Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
    Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of c-Myc determines sensitivity to 2-methoxyestradiol-induced apoptosis in human acute myeloid leukemia.
    Chow JM; Liu CR; Lin CP; Lee CN; Cheng YC; Lin S; Liu HE
    Exp Hematol; 2008 Feb; 36(2):140-8. PubMed ID: 18206725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of MYCN related genes in pediatric neuroblastoma: a study based on TARGET and GEO datasets.
    Wang H; Wang X; Xu L; Zhang J; Cao H
    BMC Pediatr; 2020 Jun; 20(1):314. PubMed ID: 32593299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the intrinsic but not the extrinsic apoptosis pathway accelerates and drives MYC-driven tumorigenesis towards acute myeloid leukemia.
    Högstrand K; Hejll E; Sander B; Rozell B; Larsson LG; Grandien A
    PLoS One; 2012; 7(2):e31366. PubMed ID: 22393362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice.
    Kawagoe H; Kandilci A; Kranenburg TA; Grosveld GC
    Cancer Res; 2007 Nov; 67(22):10677-85. PubMed ID: 18006809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression.
    Yamazaki H; Suzuki M; Otsuki A; Shimizu R; Bresnick EH; Engel JD; Yamamoto M
    Cancer Cell; 2014 Apr; 25(4):415-27. PubMed ID: 24703906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and laboratory features of pediatric acute myeloid leukemia with inversion of chromosome 16].
    He YX; Xue YQ; Wang HY; Yang NC; Shao XJ; Xu J; Ji ZH; Huang YP; Ding YF; Hu SY
    Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):593-7. PubMed ID: 23158736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.
    Zhang L; Li J; Xu H; Shao X; Fu L; Hou Y; Hao C; Li W; Joshi K; Wei W; Xu Y; Zhang F; Dai S; Breslin P; Zhang J; Zhang J
    Blood; 2020 Apr; 135(14):1133-1145. PubMed ID: 32040550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct and indirect targeting of MYC to treat acute myeloid leukemia.
    Brondfield S; Umesh S; Corella A; Zuber J; Rappaport AR; Gaillard C; Lowe SW; Goga A; Kogan SC
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):35-46. PubMed ID: 25956709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant activation of RPB1 is critical for cell overgrowth in acute myeloid leukemia.
    Yu Q; Xu Y; Zhuang H; Wu Z; Zhang L; Li J; Yang L; Wu B; Wang P; Zhang X; Gan X; Liang Y; Zheng S; Yu X; Gu Y; Xu R
    Exp Cell Res; 2019 Nov; 384(2):111653. PubMed ID: 31574286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype.
    Huh YO; Tang G; Talwalkar SS; Khoury JD; Ohanian M; Bueso-Ramos CE; Abruzzo LV
    Cancer Genet; 2016; 209(7-8):313-20. PubMed ID: 27318442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations.
    Luo H; Li Q; O'Neal J; Kreisel F; Le Beau MM; Tomasson MH
    Blood; 2005 Oct; 106(7):2452-61. PubMed ID: 15972450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level MYC expression associates with poor survival in patients with acute myeloid leukemia and collaborates with overexpressed p53 in leukemic transformation in patients with myelodysplastic syndrome.
    Gao L; Saeed A; Golem S; Zhang D; Woodroof J; McGuirk J; Ganguly S; Abhyankar S; Lin TL; Cui W
    Int J Lab Hematol; 2021 Feb; 43(1):99-109. PubMed ID: 32812335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemia.
    Zhou J; Bi C; Ching YQ; Chooi JY; Lu X; Quah JY; Toh SH; Chan ZL; Tan TZ; Chong PS; Chng WJ
    J Hematol Oncol; 2017 Jul; 10(1):138. PubMed ID: 28693523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
    Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA
    Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.